Expert Insights on Osteoporosis
A New York jury awarded $8 million to plaintiff 72-year-old Shirley Boles from Fort Walton, Florida who claimed Merck’s osteoporosis drug Fosamax destroyed her jawbone causing serious pain and disability. The jury concluded that Fosamax was “unreasonably dangerous due to defective design, and that its defective design was a legal cause of Mrs. Boles’ injury.”… Read more
Research Article: Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur Dennis M. Black, et al for the Fracture Intervention Trial and HORIZON Pivotal Fracture Trial Steering Committees. New England Journal of Medicine. 2010 May 13;362(19):1761-71. Epub 2010 Mar 24. Background. Bisphosphonates are a class of drugs commonly prescribed for patients who have osteoporosis and… Read more
Barely a minute went by after the ABC World News report on atypical fractures in women taking Fosamax and my cell phone starting ringing. “Dr. Di,” one friend said, “I just watched the evening news and I am in a panic. Should I stop my medicine?”